Search

Search Constraints

You searched for: Author/Creator Rozema, Tom

Search Results

1. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer. (2nd August 2020)

2. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer. (April 2021)

3. Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making. Issue 2 (November 2015)

4. Deciphering the glioblastoma phenotype by computed tomography radiomics. (July 2021)

5. Early local recurrence and one-year mortality of rectal cancer after restricting the neoadjuvant therapy regime. Issue 4 (April 2019)

6. MRI‐based guidelines for selective neoadjuvant treatment in rectal cancer: Does MRI adequately predict the indication for radiotherapy in daily practice in a large teaching hospital. (21st December 2019)

7. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Issue 9 (September 2015)

8. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Issue 9 (September 2015)

9. O200 10-YEAR FOLLOW-UP OF A RANDOMISED CONTROLLED TRIAL COMPARING NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY VERSUS SURGERY ALONE FOR OESOPHAGEAL OR JUNCTIONAL CANCER (CROSS). (23rd November 2019)